AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
BIOSTEM TECHNOLOGIES NEW
OTC Link · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001SC0G68
1.57▼ 0.09 (-5.42%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.66
Day's Range
1.57 – 1.74
52-Week Range
1.45 – 8.40
Volume
133.8K
Avg Volume
163.9K
Share Statistics
Shares Outstanding
Employees
—
Exchange
OTC Link
Listed
—
Share count as of August 12, 2026

BIOSTEM TECHNOLOGIES NEW (BSEM) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about BIOSTEM TECHNOLOGIES NEW (BSEM)
What is BIOSTEM TECHNOLOGIES NEW's Market Cap?
BIOSTEM TECHNOLOGIES NEW's Market Cap is $28.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BSEMAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Revenue
Cost of goods sold
Gross profit
% of revenue61.3%
Sales and marketing
General and administrative
Research and development
Depreciation and amortization
Total operating expenses
% of revenue167.6%
(Loss) income from operations
% of revenue-106.3%
Other (expense) income
Interest income, net
Other (expense) income
Other (expense) income, net
Total (loss) income from operations before income taxes
Income tax expense
Net (loss) income
% of revenue-113.6%
Basic (loss) income per common share
Diluted (loss) income per common share